Tag: Excipients

Justifying Strategies Against Reference Standard Misuse During Routine Testing In the pharmaceutical industry, ensuring the integrity of quality control testing is vital for maintaining compliance with regulatory standards and for…

Addressing the Misuse of Reference Standards During Supplier Qualification: A Comprehensive Investigation In the pharmaceutical manufacturing environment, the integrity of reference standards during supplier qualification plays a crucial role in…

Addressing Test Method Non-Compliance During Regulatory Inspections In the pharmaceutical manufacturing sector, adherence to specified test methods is critical for compliance with regulatory standards. Non-compliance during inspections can lead to…

Analyzing Reference Standard Misuse During Submission Support: A Detailed Investigation In pharmaceutical manufacturing, ensuring compliance with pharmacopoeial standards such as USP, EP, and IP is critical. However, misuse of reference…

Addressing Unjustified In-House Specifications During Audit Reviews for USP/EP/IP Compliance In the pharmaceutical manufacturing landscape, in-house specifications that deviate from regulatory standards can lead to serious compliance risks during audits.…

Addressing Test Method Non-Compliance During Submission Support: A Structured Investigation During the submission process for pharmaceutical products, the detection of test method non-compliance can escalate into significant quality risks and…

Justifying Pharmacopoeial Changes Not Implemented During Audit Review In the highly regulated world of pharmaceutical manufacturing, adherence to pharmacopoeial standards is crucial for ensuring product quality and regulatory compliance. However,…

Strategies for Addressing Test Method Non-Compliance in Routine Testing Test method non-compliance during routine testing can lead to serious implications for product quality, regulatory compliance, and ultimately, market access. This…

Addressing Unjustified In-house Specifications During Routine Testing: A Practical Justification Strategy In pharmaceutical manufacturing, the establishment of in-house specifications during routine testing can pose significant compliance and quality challenges. The…

Analysis of Compliance Gaps Related to Outdated Pharmacopoeial Monographs in Pharmaceutical Manufacturing Pharmaceutical manufacturers are often confronted with the challenge of ensuring compliance with current pharmacopoeial standards during inspections. The…

Utilizing Updated Pharmacopoeial Monographs During Audit Reviews: Ensuring Compliance and Preventing Issues In the highly regulated environment of pharmaceutical manufacturing, adherence to current standards is non-negotiable. An outdated pharmacopoeial monograph…

Investigating Unjustified In-House Specifications During Regulatory Audits In the pharmaceutical industry, ensuring that specifications align with regulatory standards is vital for maintaining compliance and product quality. An unjustified in-house specification…